The Executive Guide to Wearables & RPM in 2026

Every technology budget tells a story, and in wearables & rpm the 2026 story is one of consolidation, evidence, and reimbursement finally catching up with capability. This guide distills what we hear from operators and what the data shows into a working brief for executives.

Start with the problem, not the product

The costliest failures in this category share a root cause: technology purchased before the workflow, staffing, and payment model to absorb it existed. The discipline that separates successful programs is unglamorous - governance first, a narrowly scoped pilot second, measurement third, and scale only when the first three hold.

The market reality

Consider the current numbers: global wearable shipments now exceed 136.5 million units per quarter.

Meanwhile, oura has sold 5.5 million rings, projects roughly $1.5 billion in 2026 revenue, and has filed confidentially for an IPO (our coverage).

Meanwhile, medicare remote patient monitoring spending has passed $500 million a year, and CMS has proposed consolidating seventeen RPM codes into four by 2027 (our coverage).

Meanwhile, dexcom won authorization for a 15.5-day CGM sensor with 8.0% MARD accuracy (our coverage).

Questions to ask every vendor

Where is the peer-reviewed or real-world evidence, and on a population like ours? What happens to our data - who trains on it, who profits from it? What does integration actually require from our EHR team? And what is the exit: if we terminate, what do we keep? Vendors comfortable with these questions tend to be the ones still standing in three years.

The bottom line

Wearables & RPM rewards patient, evidence-driven adopters. Track the category daily on our Wearables & RPM page and the topic feeds beneath it.